Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events

Yusuf, Salim, Diener, Hans-Christoph, Sacco, Ralph L., Cotton, Daniel, Ôunpuu, Stephanie, Lawton, William A., Palesch, Yuko, Martin, Reneé H. +26 more·2008·New England Journal of Medicine
DOI 10.1056/nejmoa0804593

Cited by (785)

Items 601–700 of 785

  1. Recent advances in the management of hypertension
    José Antonio García‐Donaire, Luis Miguel Ruilope · 2010 · F1000 Medicine Reports
  2. SECONDARY PHARMACOLOGICAL PREVENTION OF CARDIOVASCULAR DISEASES: OUR ABILITY IN CLINICAL PRACTICE
    Е. В. Филиппов, Sergey S Yakushin · 2012 · Rational Pharmacotherapy in Cardiology
  3. Treatment with angiotensin receptor blockers before stroke could exert a favourable effect in acute cerebral infarction
    W.J. Elliott · 2011 · Yearbook of Cardiology
  4. Schlaganfallbehandlung 2011
    Heinrich J. Audebert · 2011 · Notfall + Rettungsmedizin
  5. Implications of Recently Published Trials of Blood Pressure–Lowering Drugs in Hypertensive or High-Risk Patients
    W.J. Elliott · 2011 · Yearbook of Cardiology
  6. Hypertension control in chronic kidney disease: don't miss the forest for the trees.
    Hean Teik Ong, Loke Meng Ong, Jacqueline J Ho · 2012 · PubMed
  7. Selecting Optimum Antihypertensive Therapy
    Vasilios Papademetriou, Michael N. Doumas · 2016 · Springer eBooks
  8. ¿Qué fármaco antihipertensivo deberíamos utilizar en pacientes con enfermedad cerebrovascular para prevenir un nuevo ictus?
    Luis Castilla‐Guerra, María del Carmen Fernández‐Moreno, Juan Manuel de la Vega-Sánchez · 2017 · Medicina Clínica
  9. Prevention and Treatment
    Flávio Danni Fuchs · 2017 · Springer eBooks
  10. Inhibicja RAAS a śmiertelność w nadciśnieniu tętniczym: od farmakologii do dowodów klinicznych
    Roberto Ferrari · 2013 · Kardiologia Polska
  11. Recomendaciones sobre el tratamiento de la hipertensión arterial en la prevención secundaria del ictus isquémico
    Cristina Sierra, Luis Castilla‐Guerra, Jaime Masjuán, Antonio Gil-Núñez, J. Álvarez-Sabín, M.I. Egocheaga, Pedro Armario · 2018 · Hipertensión y Riesgo Vascular
  12. Evidence base regarding target levels of arterial pressure in patients after a stroke: focus on a geriatric population
    Ol'ga Dmitrievna Ostroumova, Marina S. Cherniaeva · 2020 · Systemic Hypertension
  13. Cerebrovascular Disease in Hypertension
    Neil Chapman, Hisatomi Arima, John Philip Chalmers, Craig S. Anderson · 2012 · Elsevier eBooks
  14. Prognosis after Stroke
    Tatjana Rundek, Ralph L. Sacco · 2015 · Elsevier eBooks
  15. Hemmstoffe des Renin-Angiotensin-Systems
    Manfred Anlauf, Franz Weber · 2016 · Springer eBooks
  16. Hemmstoffe des Renin-Angiotensin-Systems
    Manfred Anlauf, Franz Weber · 2015 · Springer eBooks
  17. A simulation study on the antiarrhythmic mechanisms of established agents in myocardial ischemia and infarction
    Qince Li, Zheng Yan, Zhen Wang, Cuiping Liang, Xiqian Wang, Xianghu Wu, Wei Wang, Yongfeng Yuan, Kuanquan Wang · 2024 · PLoS Computational Biology
  18. Arterielle Hypertonie
    Thomas Eschenhagen A, Joachim Weil · 2025 · Springer eBooks
  19. The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 – therapy
    Nadia A. Khan, Brenda R. Hemmelgarn, Robert J. Herman, Chaim M. Bell, Jeff L. Mahon, Lawrence A. Leiter, Simon W. Rabkin, Michael D. Hill, Raj S. Padwal, Rhian M. Touyz et al. · 2009 · Canadian Journal of Cardiology
  20. Organoprotecive effects of angiotensin II receptor blockers in patients with type 2 diabetes mellitus
    Ivona Renata Yarek-Martynova, Минара Шамхаловна Шамхалова · 2010 · Diabetes Mellitus
  21. Excision of Oral Leukoplakia using 970 nm Diode Laser
    Chaya M David, Malti Agrawal, Jyoti Thakur · 2017 · International Journal of Advanced and Integrated Medical Sciences
  22. Peripheral Artery Disease
    Todd S. Perlstein, Marc Z. Krichavsky · 2012 · Elsevier eBooks
  23. Prevention and Treatment of Stroke
    Marc Fisher, Mehmet Zülküf Önal · 2012 · Elsevier eBooks
  24. Telmisartan Matrix Tablets Using Trigonella foenum-graecum Seed Mucilage: Fabrication and Description
    Kutmalge Nagaraj · 2022 · Pharmaceutical Drug Regulatory Affairs Journal
  25. Behavioral Medicine Treatments for Heart Failure
    Laura S. Redwine, Barry Greenberg, Paul J. Mills · 2022 · Springer eBooks
  26. Recurrent Stroke Prevention I: Diuretic and Angiotensin-Converting Enzyme Inhibitors (ACEIs) – The PROGRESS Trial
    Thomas K. A. Linden, Geoffrey Alan Donnan · 2010 · Humana Press eBooks
  27. Angiotensin Receptor Blockers and Stroke Therapy
    Geoffrey Alan Donnan, Stephen M. Davis · 2009 · Stroke
  28. Angiotensin-converting enzyme inhibitors will not help in improving stroke outcome if given immediately after stroke
    Rohit Bhatia · 2010 · Annals of Indian Academy of Neurology
  29. What antihypertensive drugs are prescribed for patients with stroke in Japan? —Fukuoka Stroke Registry Study—
    Hiroshi Nakane, Jiro Kitayama, Yasuhiro Kumai, Saho Higashi, Takanari Kitazono · 2010 · Nosotchu
  30. The Role of RAS Modification for Primary and Secondary Stroke Prevention
    Dan J. Fintel · 2009 · Postgraduate Medicine
  31. A Glimpse of Canaan, 40 Years On
    J. P. Mohr · 2009 · Cerebrovascular Diseases
  32. ¿Qué ha cambiado en el manejo actual de la hipertensión arterial desde el punto de vista renal?
    Javier Dı́ez · 2010 · Revista Clínica Española
  33. Telmisartan in high-risk patients intolerant of ACE inhibitors – Authors' reply
    Salim Yusuf, Janice M. Pogue, Koon Kang Teo, Craig S. Anderson, Peter Sleight · 2009 · The Lancet
  34. Joint Commission Primary Stroke Center Certification Does Not Affect Proband Enrollment: The Siblings With Ischemic Stroke Study
    Alexa N. Richie, Jorge F. Trejo, Christian G. Bowers, Rebecca B. McNeil, Dale M. Gamble, Sothear H. Luke, Robert D. Brown, Thomas G. Brott, Brett M. Kissela M. D, Bradford B. Worrall et al. · 2009 · Journal of Stroke and Cerebrovascular Diseases
  35. Inhibition of the RAS and prevention of diabetes and CVD: Mechanistic insights and lessons learned from clinical trials
    Samy I. McFarlane, JEFFREY S. BORER · 2009 · Current Diabetes Reports
  36. Controversies in stroke
    Stephen Davies, Geoffrey Alan Donnan · 2008 · The biomedical & life sciences collection.
  37. Candesartan for cardiovascular prevention in Japanese hypertensive patients with coronary heart disease
    Jan Albert Staessen, Tom Richart, W. H. Birkenhäger · 2009 · European Heart Journal
  38. Recurrent Stroke Prevention II: Angiotensin Receptor Blockers—The LIFE, MOSES, PRoFESS, and Other Trials
    Venkatesh Aiyagari, Philip B. Gorelick · 2010 · Humana Press eBooks
  39. Cerebrovascular Disease in Hypertension
    Neil Chapman, Craig S. Anderson, John Philip Chalmers · 2007 · Elsevier eBooks
  40. Role of angiotensin receptor blockers in diabetes
    Philippe Akhrass, John N. Makaryus, Amgad N. Makaryus, Arathy Vamadevan, Samy I. McFarlane · 2011
  41. Angiotensin Receptor Blockers
    W.J. Elliott, Henry Richard Black · 2007 · Elsevier eBooks
  42. What Blood Pressure Goal in Type-2 Diabetes?
    PM Nilsson · 2011 · Journal für Kardiologie (Krause & Pachernegg GmbH)
  43. In Reply: ACEI and ARB — Each Unique RAAS Inhibitors
    Kamal Awad, Carl J. Lavie, Maciej Banach · 2023 · Mayo Clinic Proceedings
  44. Grenzentscheidungen in der Schlaganfalltherapie
    Matthias Endres, Martin Grond, Werner Hacke, Martin Ebinger, Peter Dieter Schellinger, Martin Dichgans · 2011 · Der Nervenarzt
  45. The role of haptoglobin phenotype and 24-hour blood pressure characteristics in cerebral small vessel disease
    Julie Staals · 2009
  46. Therapieziele und Indikation zur medikamentösen Therapie bei arterieller Hypertonie: Update 2015 der Empfehlungen der Österreichischen Gesellschaft für Hypertensiologie
    Johann Auer, Bruno Watschinger · 2015 · Journal für Kardiologie (Krause & Pachernegg GmbH)
  47. Misleading guidelines for the diagnosis and management of hypertension
    Flávio Danni Fuchs · 2014 · Americanae (AECID Library)
  48. Hochdruck und Gefäßsystem
    Gschwandtner Me, Oliver Schlager, Andrea Willfort, Renate Koppensteiner · 2010 · Journal für Kardiologie (Krause & Pachernegg GmbH)
  49. Secondary Stroke Prevention – Medical Treatment
    Ralph Weber, HC Diener · 2009 · KARGER eBooks
  50. Hypertonie: klinische und experimentelle Forschung
    Hermann G. Haller · 2009 · Der Nephrologe
  51. The Role of Cerebrovascular Disease in Cognitive Decline
    Ana Verdelho · 2014 · Springer eBooks
  52. Serie sobre hospitalizaciones evitables y fortalecimiento de la atención primaria en salud: Revisión exploratoria de la evidencia de eficacia de la atención primaria en salud en la prevención de hospitalizaciones evitables
    Agustín Ciapponi, Demián Glujovsky, Federico M. Daray, Analía López · 2012
  53. Nephrotisches Syndrom bei Erwachsenen
    Adolf -Wilhelm Keil, Tobias Bruno Huber · 2013 · Der Nephrologe
  54. Prevention and pleiotropic therapy against stroke in the very elderly
    Setsuro Ibayashi · 2010 · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics
  55. It Takes the Right Medications to Prevent a Million Heart Attacks and Strokes
    James J. DiNicolantonio, Flávio Danni Fuchs, James Henry O’Keefe · 2014 · Postgraduate Medicine
  56. New options for therapeutic management of patients with cardiovascular disease. A closer look at clinical trials with telmisartan
    Massimo Volpe · 2009 · Hot Topics in Hypertension
  57. Optimal blood pressure targets in 2014 – Does the guideline recommendation match the evidence base?
    C A Alviar, Sripal Bangalore, Franz H. Messerli · 2015 · Hipertensión y Riesgo Vascular
  58. Estrategias adecuadas en la enfermedad cardiovascular. Los pacientes de alto riesgo
    Juliana Caballero Güeto, Miguel Ángel Ulecia Martínez, Emilio González Cocina, Manuel Lagares Carballo · 2009 · Medicina Clínica
  59. How useful are hypertension guidelines for diabetes?
    Peter M. Nilsson · 2013 · Diabetes Management
  60. Lower, faster, better: the delusions of surrogate markers in hypertension
    Anthony S. Wierzbicki, Albert Ferro · 2013 · International Journal of Clinical Practice
  61. Papel actual de los antagonistas de los receptores de la angiotensina II y de sus combinaciones en el tratamiento de la hipertensión arterial
    Pedro Armario, R. Hernández del Rey, Anna Oliveras · 2009 · Medicina Clínica
  62. Magic ARB, or magic trial?
    Iwao Kuwajima · 2010 · Hypertension Research
  63. Antidiabetogenic effects of telmisartan: evidence from clinical trials
    Alejandro de la Sierra · 2010 · Hot Topics in Cardiometabolic Disorders
  64. Valsartan and Amlodipine: Safety and Efficacy in Stroke Prevention
    Kanako Bokuda and A. Ichihara · 2010 · Clinical Medicine Reviews in Vascular Health
  65. Learning a lesson from the past
    Masaki Mogi · 2009 · Hypertension Research
  66. The role of ACE inhibitors and angiotensin receptor blockers in the treatment of hypertension and cardiovascular disease
    J. Susie Woo, Jeffrey L. Probstfield · 2009 · Current Cardiovascular Risk Reports
  67. Gaps in the ARB Knowledge Base: Are ARBs Effective Anti–Atrial Fibrillation Agents?
    Peter Russell Kowey · 2009 · Journal of Clinical Hypertension
  68. Telmisartan in high-risk patients intolerant of ACE inhibitors
    Alistair S. Hall, Martin H. Strauss · 2009 · The Lancet
  69. Treatment of patients with post-stroke dementia
    Marie‐Anne Mackowiak, Florence Pasquier · 2013 · Cambridge University Press eBooks
  70. Recommendations to choose the primary endpoint in cardiovascular clinical trials
    Guadalupe Gómez Melis, Moisés Gómez Mateu, Urania G. Dafni · 2013
  71. Bericht vom NeuroUpdate der Med-Update-Reihe in Wiesbaden (13./14.02.09)
    Marianne Dieterich, Gerhard F. Hamann · 2009 · Der Nervenarzt
  72. Gebruik van telmisartan ter voorkoming van herhaalde beroertes en hartproblemen
    Teun van Gelder · 2009 · Medisch-Farmaceutische Mededelingen
  73. Sekundärprophylaxe des Schlaganfalls aus neurologischer Perspektive
    Günter Seidel · 2013 · Herz
  74. Chapter 13 Hypertension
    Sverre Erik Kjeldsen, Tonje Amb Aksnes, Robert H. Fagard, Giuseppe Mancia · 2009
  75. Invited review Morbidity and mortality trials: black and white or shades of grey?
    Gordon T. McInnes · 2009
  76. Therapieziele und Indikation zur medikamentösen Therapie bei arterieller Hypertonie: Update 2015 der Empfehlungen der Österreichischen Gesellschaft
    Johann Auer, Bruno Watschinger · 2015
  77. Hemmstoffe des Renin-Angiotensin-Systems
    Manfred Anlauf · 2009 · Springer eBooks
  78. ACE Inhibitor ARB Controversies
    M. GABRIEL KHAN · 2014 · Contemporary cardiology
  79. [Guideline for hypertension treatment in patients with cerebrovascular diseases after acute phase].
    Luis Manuel Murillo-Bonilla, Lucía Lepe-Cameros, Carlos Alberto Espinoza-Casillas, Adolfo Leyva-Rendón, Minerva López, Carolina León-Jiménez, Guillermo Enríquez-Coronel, Antonio Araúz, Carlos Cantú, Jaime Lizola-Hernández et al. · 2010 · PubMed
  80. Secondary Prevention After Ischemic Lacunar Stroke
    Raffaella Valenti, Leonardo Pantoni · 2015 · Springer eBooks
  81. Pre-hypertension and central aortic haemodynamics
    Hendrik L. Booysen · 2015
  82. Traditional Stroke Risk Factor Treatment
    Shelly D. Ozark, Bruce Ovbiagele · 2015 · Springer eBooks
  83. Telmisartan to Prevent Recurrent Stroke — No Benefit
    Allan S. Brett · 2008 · Journal watch
  84. Hipertensão sistólica isolada e risco associado ao acidente vascular encefálico: implicações para o tratamentosystolic hypertension and risk of stroke: treatment implications
    Roberto Dischinger Miranda, Rafael Alessandro Ferreira Gomes, Audes Magalhães, Diógenes Feitosa, Marco Antônio Mota Gomes, Carlos André Uehara · 2009
  85. PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
    Sergey Anatol'evich Boytsov, Колос Игорь Петрович · 2008 · Rational Pharmacotherapy in Cardiology
  86. Preventing Stroke Recurrence: How Best to Control Hypertension?
    Harlan M. Krumholz, Sm · 2008 · Journal watch
  87. 5) Cerebrovascular Disease
    Shinichiro Uchiyama · 2009 · Nihon Naika Gakkai Zasshi
  88. Landscape of Combination Therapy – Which Way Forward? Proceedings of the Satellite Symposium Held at the ESH European Meeting on Hypertension and Cardiovascular Protection, 27 April 2012, London
    Patricia Fonseca, Anna F. Dominiczak, Stephen B. Harrap · 2012 · European Cardiology Review
  89. Abdulahad, W. H., Stegeman, C. A., Limburg, P. C., Kallenberg, C. G. A. Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission. ARTHRITIS AND RHEUMATISM 58(7): 2196-2205, 2008 UMCG Disciplinegroep: PAT-LAB IGK REUMA NEFRO
    R. Poly · 2008
  90. Revisão das orientações terapêuticas da hipertensão arterial em ambulatório
    Relva, Dinis Emanuel Barracosa · 2014 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  91. 2. Treatment of Complicated Hypertension. 4) Management of Hypertension in Acute and Chronic Stroke Patients.
    Kazuo Kitagawa · 2011 · Nihon Naika Gakkai Zasshi
  92. Best Practices in Neurological Care
    Bruce Ovbiagele · 2014
  93. Clinical Applications of Renin–Angiotensin System Inhibitors
    Michel Burnier · 2012
  94. Aktuelle Studienlage zur Sekundärprävention
    Christian Hans Nolte, Matthias Endres · 2013 · DNP - Der Neurologe und Psychiater
  95. European and British Guidelines on Hypertension
    Giuseppe Mancia, Guido M. Grassi, W.J. Elliott, Bryan Williams · 2012 · Elsevier eBooks
  96. Cognitive consequences of cerebral small vessel disease
    José Manuel Ferro, Ana Verdelho, Sofia Madureira · 2014 · Cambridge University Press eBooks
  97. RESIDUAL RISK AND RESISTANCE TO THE BENEFITS OF ANTIHYPERTENSIVE TREATMENT
    Alberto Zanchetti · 2014 · CRC Press eBooks
  98. Effective inhibition of renin-angiotensin-aldosterone system: the angiotensin-converting enzyme inhibitors benefits
    Сергей Валентинович Столов · 2014 · HYPERTENSION
  99. Эссенциальная гипертензия у пациентов с сахарным диабетом 2-го типа: актуальные вопросы антигипертензивной терапии в свете медицины, основанной на доказательствах
    Антон Владимирович Барсуков · 2011 · CyberLeninK (CyberLeninka)
  100. Prevention and Treatment of Atrial Fibrillation in Patients with Hypertension
    Sverre Erik Kjeldsen, Tonje Amb Aksnes, Serap E. Erdine, Athanasios John Manolis · 2016 · Springer eBooks